Share chart ADC Therapeutics SA
Extended chart
Simple chart
About ADC Therapeutics SA
ADC Therapeutics SA, биотехнологическая компания, специализирующаяся на клинических онкологиях, разрабатывает конъюгаты антител и лекарств (ADC) для пациентов, страдающих гематологическими злокачественными новообразованиями и солидными опухолями. more details| IPO date | 1979-03-16 |
|---|---|
| ISIN | CH0499880968 |
| Industry | Communications Equipment |
| Sector | Information Technology |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.adctherapeutics.com |
| Цена ао | 1.34 |
| Change price per day: | 0% (1.34) |
|---|---|
| Change price per week: | +3.88% (1.29) |
| Change price per month: | +9.84% (1.22) |
| Change price per 3 month: | -3.6% (1.39) |
| Change price per half year: | -52.48% (2.82) |
| Change price per year: | -68.02% (4.19) |
| Change price per 3 year: | -82.16% (7.51) |
| Change price per 5 year: | -96.53% (38.59) |
| Change price per year to date: | -36.79% (2.12) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
|---|---|---|---|---|---|---|---|---|---|
| 04.12.2024 | 06.12.2024 | Redmile Group, LLC 10% Owner |
Sale | 2.07 | 52 479 | 25352 | 0 | -0.03 | link |
| 17.06.2024 | 18.06.2024 | Squarer Ron Director |
Sale | 2.89 | 20 216 | 6995 | 0 | -0.01 | link |
| 17.06.2024 | 18.06.2024 | Sandor Victor Director |
Sale | 2.89 | 20 216 | 6995 | 0 | -0.01 | link |
| 17.06.2024 | 18.06.2024 | Pfisterer Thomas Director |
Sale | 2.89 | 4 153 | 1437 | 0 | 0 | link |
| 17.06.2024 | 18.06.2024 | Monges Viviane Director |
Sale | 2.89 | 4 153 | 1437 | 0 | 0 | link |
| 17.06.2024 | 18.06.2024 | Hug Peter Director |
Sale | 2.89 | 3 448 | 1193 | 0 | 0 | link |
| 07.05.2024 | 09.05.2024 | MALLIK AMEET Chief Executive Officer |
Sale | 4.48 | 133 195 | 29731 | 0 | -0.04 | link |
| Institutions | Volume | Share, % |
|---|---|---|
| Redmile Group, LLC | 15328317 | 18.57 |
| Prosight Management, LP | 6471800 | 7.84 |
| Millennium Management LLC | 2672810 | 3.24 |
| Citadel Advisors Llc | 1853412 | 2.25 |
| Bank of America Corporation | 1525741 | 1.85 |
| Goldman Sachs Group Inc | 1459514 | 1.77 |
| Affinity Asset Advisors, LLC | 1013540 | 1.23 |
| Vantage Consulting Group, Inc | 850737 | 1.03 |
| Morgan Stanley | 781937 | 0.95 |
| Blue Owl Capital Holdings LP | 733568 | 0.89 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Amanda Hamilton | Investor Relations Officer | N/A | |
| Ms. Kimberly Pope | Senior VP & Chief People Officer | N/A | 1967 (58 years) |
| Dr. Ameet Mallik M.B.A., M.S. | CEO & Director | 1.84M | 1973 (52 years) |
| Mr. Jose I. Carmona M.B.A. | Chief Financial Officer | 884.86k | 1972 (53 years) |
| Dr. Michael Mulkerrin Ph.D. | Chief Technical Operations Officer | N/A | 1955 (70 years) |
| Dr. Patrick van Berkel Ph.D. | Chief Scientific Officer | N/A | 1969 (56 years) |
| Mr. Peter J. Graham Esq. | Secretary & Chief Legal Officer | N/A | 1967 (58 years) |
| Dr. Mohamed Zaki M.D., Ph.D. | Chief Medical Officer | 2.41M | 1965 (60 years) |
| Ms. Lisa Michelle Kallebo | Corporate Controller & Chief Accounting Officer | N/A | |
| Ms. Eugenia Litz | Vice President of Investor Relations & Corporate Communications | N/A |
Address: Switzerland, Epalinges, Biopole - open in Google maps, open in Yandex maps
Website: http://www.adctherapeutics.com
Website: http://www.adctherapeutics.com
